[1]
|
World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard[EB/OL ]. (2020-12-09)[2020-12-09]. https://covid19.who.int/. |
[2]
|
Centers for Disease Control and Prevention. Coronavirus (COVID-19)[EB/OL]. (2020-12-08)[2020-12-09]. https://www.cdc.gov/coronavirus/2019-ncov/index.html. |
[3]
|
European Centre for Disease Prevention and Control. COVID-19 pandemic[EB/OL ]. (2020-12-08)[2020-12-09]. https://www.ecdc.europa.eu/en/COVID-19-pandemic. |
[4]
|
Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence[J]. Lancet, 2009, 374: 86-89. doi: 10.1016/S0140-6736(09)60329-9 |
[5]
|
Glasziou PP, Sanders S, Hoffmann T. Waste in COVID-19 research[J]. BMJ, 2020, 369: m1847. http://www.bmj.com/content/369/bmj.m1847/rr-8 |
[6]
|
Budhathoki P, Shrestha DB, Rawal E, et al. Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis[J]. SN Compr Clin Med, 2020, 19: 1-21. doi: 10.1007/s42399-020-00515-6 |
[7]
|
Cano EJ, Fonseca Fuentes X, Corsini Campioli C, et al. Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis[J]. Chest, 2021, 159: 1019-1040. doi: 10.1016/j.chest.2020.10.054 |
[8]
|
Cheng WW, Li YF, Cui LY, et al. Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis[J]. Front Pharmacol, 2020, 11: 571156. doi: 10.3389/fphar.2020.571156 |
[9]
|
Halpin DMG, Singh D, Hadfield RM. Inhaled corticos-teroids and COVID-19: a systematic review and clinical perspective[J]. Eur Respir J, 2020, 55: 2001009. doi: 10.1183/13993003.01009-2020 |
[10]
|
Lee KH, Yoon S, Jeong GH, et al. Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis[J]. J Clin Med, 2020, 9: 2392. doi: 10.3390/jcm9082392 |
[11]
|
Li H, Chen CX, Hu F, et al. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis[J]. Leukemia, 2020, 34: 1503-1511. doi: 10.1038/s41375-020-0848-3 |
[12]
|
Shuto H, Komiya K, Yamasue M, et al. A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19[J]. Sci Rep, 2020, 10: 20935. doi: 10.1038/s41598-020-78054-2 |
[13]
|
Singh AK, Majumdar S, Singh R, et al. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective[J]. Diabetes Metab Syndr, 2020, 14: 971-978. doi: 10.1016/j.dsx.2020.06.054 |
[14]
|
Sterne JAC, Diaz J, Villar J, et al. Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials[J]. Trials, 2020, 21: 734. doi: 10.1186/s13063-020-04641-3 |
[15]
|
Tlayjeh H, Mhish OH, Enani MA, et al. Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis[J]. J Infect Public Health, 2020, 13: 1652-1663. doi: 10.1016/j.jiph.2020.09.008 |
[16]
|
Veronese N, Demurtas J, Yang L, et al. Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature[J]. Front Med (Lausanne), 2020, 7: 170. http://www.researchgate.net/publication/340628790_Use_of_Corticosteroids_in_Coronavirus_Disease_2019_Pneumonia_A_Systematic_Review_of_the_Literature |
[17]
|
Yang ZW, Liu JL, Zhou YJ, et al. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis[J]. J Infect, 2020, 81: e13-e20. http://www.sciencedirect.com/science/article/pii/S0163445320301912?via%3Dihub |
[18]
|
Ye Z, Wang Y, Colunga-Lozano LE, et al. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis[J]. CMAJ, 2020, 192: E756-E767. doi: 10.1503/cmaj.200645 |
[19]
|
Sharma SK, Mishra M, Mudgal SK. Efficacy of cloth face mask in prevention of novel coronavirus infection transmis-sion: A systematic review and meta-analysis[J]. J Educ Health Promot, 2020, 9: 192. doi: 10.4103/jehp.jehp_533_20 |
[20]
|
Long Y, Hu T, Liu L, et al. Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis[J]. J Evid Based Med, 2020, 13: 93-101. doi: 10.1111/jebm.12381 |
[21]
|
Liang M, Gao L, Cheng C, et al. Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis[J]. Travel Med Infect Dis, 2020, 36: 101751. doi: 10.1016/j.tmaid.2020.101751 |
[22]
|
Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses[J]. Cochrane Database Syst Rev, 2020(11): CD006207. |
[23]
|
Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis[J]. Lancet, 2020, 395: 1973-1987. doi: 10.1016/S0140-6736(20)31142-9 |
[24]
|
Camargo MC, Martinez-Silveira MS, Lima AA, et al. Effectiveness of the use of non-woven face mask to prevent coronavirus infections in the general population: a rapid systematic review[J]. Cien Saude Colet, 2020, 25: 3365-3376. doi: 10.1590/1413-81232020259.13622020 |
[25]
|
Brainard J, Jones NR, Lake IR, et al. Community use of face masks and similar barriers to prevent respiratory illness such as COVID-19: a rapid scoping review[J]. Euro Surveill, 2020, 25: 2000725. |
[26]
|
Aggarwal N, Dwarakanathan V, Gautam N, et al. Facemasks for prevention of viral respiratory infections in community settings: A systematic review and meta-analysis[J]. Indian J Public Health, 2020, 64: S192-S200. doi: 10.4103/ijph.IJPH_470_20 |
[27]
|
Casigliani V, De Nard F, De Vita E, et al. Too much information, too little evidence: is waste in research fuelling the COVID-19 infodemic?[J]. BMJ, 2020, 370: m2672. http://www.bmj.com/content/370/bmj.m2672 |
[28]
|
Landhuis E. Scientific literature: Information overload[J]. Nature, 2016, 535: 457-458. doi: 10.1038/nj7612-457a |
[29]
|
Sampson M, Shojania KG, Garritty C, et al. Systematic reviews can be produced and published faster[J]. J Clin Epidemiol, 2008, 61: 531-536. doi: 10.1016/j.jclinepi.2008.02.004 |
[30]
|
Elliott JH, Turner T, Clavisi O, et al. Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap[J]. PLoS Med, 2014, 11: e1001603. doi: 10.1371/journal.pmed.1001603 |
[31]
|
Jadad AR, Cook DJ, Jones A, et al. Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals[J]. JAMA, 1998, 280: 278-280. doi: 10.1001/jama.280.3.278 |
[32]
|
Shojania KG, Sampson M, Ansari MT, et al. How quickly do systematic reviews go out of date? A survival analysis[J]. Ann Intern Med, 2007, 147: 224-233. doi: 10.7326/0003-4819-147-4-200708210-00179 |
[33]
|
靳英辉, 蔡林, 程真顺, 等. 新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(标准版)[J]. 解放军医学杂志, 2020, 45: 1-20. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJY202001002.htm
Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)[J]. Jiefangjun Yixue Zazhi, 2020, 45: 1-20. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJY202001002.htm |
[34]
|
Dagens A, Sigfrid L, Cai E, et al. Scope, quality, and inclusivity of clinical guidelines produced early in the COVID-19 pandemic: rapid review[J]. BMJ, 2020, 369: m1936. http://www.bmj.com/content/369/bmj.m1936 |
[35]
|
Brouwers MC, Kerkvliet K, Spithoff K, et al. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines[J]. BMJ, 2016, 352: i1152. http://www.ncbi.nlm.nih.gov/pubmed/26957104 |
[36]
|
World Health Organization. WHO handbook for guideline development. 2nd edition[M/OL ]. [2020-12-09]. https://apps.who.int/iris/handle/10665/145714. |
[37]
|
Garritty CM, Norris SL, Moher D. Developing WHO rapid advice guidelines in the setting of a public health emergency[J]. J Clin Epidemiol, 2017, 82: 47-60. doi: 10.1016/j.jclinepi.2016.08.010 |
[38]
|
World Health Organization. Rapid risk assessment of acute public health events[EB/OL ]. [2020-12-09]. https://www.who.int/csr/resources/publications/HSE_GAR_ARO_2012_1/en/. |
[39]
|
World Health Organization. Emergency Response Framework (ERF)[EB/OL]. [2020-12-09]. https://www.who.int/hac/about/erf/en/. |
[40]
|
Kowalski SC, Morgan RL, Falavigna M, et al. Develop-ment of rapid guidelines: 1. Systematic survey of current practices and methods[J]. Health Res Policy Syst, 2018, 16: 61. doi: 10.1186/s12961-018-0327-8 |
[41]
|
The BMJ. BMJ Rapid Recommendations[EB/OL ]. (2020-12-17)[2020-12-30]. https://www.bmj.com/rapid-recommendations. |
[42]
|
Rochwerg B, Agarwal A, Zeng L, et al. Remdesivir for severe COVID-19: a clinical practice guideline[EB/OL ]. (2020-07-30)[2020-12-30]. https://www.bmj.com/content/370/bmj.m2924. |
[43]
|
National Institutes of Health. COVID-19 treatment guidelines[EB/OL ]. (2020-11-27)[2020-12-30]. https://www.covid19treatmentguidelines.nih.gov/whats-new/. |
[44]
|
Up to Date. Coronavirus disease 2019 (COVID-19): management in hospitalized adults[EB/OL ]. (2020-11-27)[2020-12-30]. https://www.uptodate.com/contents/coronavirus-disease-2019-COVID-19-management-in-hospitalized-adults. |
[45]
|
Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of COVID-19-Final Report[J]. N Engl J Med, 2020, 383: 1813-1826. doi: 10.1056/NEJMoa2007764 |
[46]
|
Lamontagne F, Agoritsas T, Macdonald H, et al. A living WHO guideline on drugs for COVID-19[EB/OL ]. (2020-09-04)[2021-02-02]. https://www.bmj.com/content/370/bmj.m3379. |
[47]
|
World Health Organization. Corticosteroids for COVID-19: living guidance[EB/OL ]. (2020-09-02)[2021-02-02]. https://apps.who.int/iris/handle/10665/334125. |
[48]
|
Graham R, Mancher M, Wolman DM, et al. Clinical practice guidelines we can trust[M]. Washington DC: the National Academies Press, 2011. |
[49]
|
Elliott JH, Synnot A, Turner T, et al. Living systematic review: 1. Introduction-the why, what, when, and how[J]. J Clin Epidemiol, 2017, 91: 23-30. doi: 10.1016/j.jclinepi.2017.08.010 |
[50]
|
Thomas J, Noel-Storr A, Marshall I, et al. Living systematic reviews: 2. Combining human and machine effort[J]. J Clin Epidemiol, 2017, 91: 31-37. doi: 10.1016/j.jclinepi.2017.08.011 |
[51]
|
Simmonds M, Salanti G, McKenzie J, et al. Living Systematic Review Network. Living systematic reviews: 3. Statistical methods for updating meta-analyses[J]. J Clin Epidemiol, 2017, 91: 38-46. doi: 10.1016/j.jclinepi.2017.08.008 |
[52]
|
Akl EA, Meerpohl JJ, Elliott J, et al. Living Systematic Review Network. Living systematic reviews: 4. Living guideline recommendations[J]. J Clin Epidemiol, 2017, 91: 47-53. doi: 10.1016/j.jclinepi.2017.08.009 |
[53]
|
许吉, 邓宏勇. 动态系统评价简介[J]. 中国循证医学杂志, 2020, 20: 244-248. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ202002018.htm
Xu J, Deng HY. A brief introduction of living systematic review[J]. Zhongguo Xunzheng Yixue Zazhi, 2020, 20: 244-248. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ202002018.htm |
[54]
|
张迁, 王琪, 后亮瑛, 等. 动态指南制订方法及案例介绍[J]. 中国循证医学杂志, 2021, 21: 491-496. |
[55]
|
MAGIC. Our approach[EB/OL ]. (2020-12-11)[2020-12-11]. https://magicevidence.org/approach/. |